Barcelona, Spain

Andreas Meyerhans

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Azienda Ospedaliera Universitaria Senese. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Meyerhans. Retrieved from https://idiyas.com/inventor/andreas-meyerhans-2egtz49e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andreas Meyerhans

Introduction

Andreas Meyerhans is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of viral diseases. His work has led to the development of innovative compounds that target specific biological processes.

Latest Patents

Meyerhans holds a patent for "Human helicase DDX3 inhibitors as therapeutic agents." This invention refers to compounds endowed with RNA helicase DDX3 inhibitory activity, which are designed for therapeutic use, especially in combating viral infections. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Meyerhans has worked with esteemed organizations such as Azienda Ospedaliera Universitaria Senese and Helmholtz-Zentrum für Infektionsforschung GmbH. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Meyerhans has collaborated with notable colleagues, including Miguel Angel Martinez De La Sierra and Annalaura Brai. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Andreas Meyerhans is a distinguished inventor whose work in developing therapeutic agents has the potential to significantly impact the treatment of viral diseases. His innovative approach and collaborations highlight the importance of teamwork in advancing scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…